Sarah is current president of Society for Participatory Medicine and is CEO and Executive Director of CANCER101, a patient advocacy organization whose quest it is to help patients and caregivers navigate their cancer journey. Driven by a passion to make an impact in patient care and engagement, Sarah has held a variety of roles within health care including various roles with Pfizer.
